Insilico Medicine (Pharma.AI)
Data
Accelerating drug discovery through an end-to-end generative AI pipeline for target identification, molecular design, and clinical trial prediction.
View
Discover the strongest tools and workflows for biomarker discovery.
Data
Accelerating drug discovery through an end-to-end generative AI pipeline for target identification, molecular design, and clinical trial prediction.
Data
Accelerating drug discovery and precision medicine through federated learning and multi-modal AI.
Business
Accelerate drug discovery workflows with AI-driven evidence synthesis and biological insight.
Learning
Empowering early cancer detection through a multiomics AI platform and routine blood tests.
Business
The AI-driven pharmatech company translating patient data into precision medicines through automated molecular design.
Development
Augmenting human intelligence to discover and develop life-changing medicines via end-to-end AI drug discovery.
Development
AI-driven cardiology-as-a-service for precision arrhythmia detection and cardiac remote monitoring.
Development
AI-driven drug discovery for metabolic and age-related diseases using human longitudinal data.
Business
Accelerating life sciences and healthcare outcomes via regulatory-grade Real-World Evidence and AI.
Development
Pioneering hypothesis-free drug discovery through the Interrogative Biology® platform and Causal AI.
Development
Unifying life sciences data into an actionable knowledge graph for accelerated drug discovery.
Data
Ubiquitous generative intelligence integrated across the global communication fabric.
Data
The premier digital ecosystem for cross-disciplinary scholarly research and Oxford University Press publications.
Data
Deciphering the language of biology through multi-modal AI and deep clinical insights.
Data
Google's most capable AI model with advanced reasoning and million-token context
Data
Empowering retail investors with institutional-grade AI analytics and real-time global market data.
Data
The Modern PR Management Platform for Smarter Media Relations and Real-Time Insights.
